SPG11: clinical and genetic features of seven Czech patients and literature review
Kristýna Dolečková(Charles University), Anna Uhrová Mészárosová(Charles University), Vladimir Sigut, Júlia Štellmachová(University Hospital Olomouc), Tomáš Gescheidt(University Hospital Brno), Emílie Vyhnálková(Charles University), Jan Roth(Charles University), Robert Jech(Charles University), Martin Vyhnálek(Charles University), Pavel Houska(Strakonice Hospital), Pavel Seeman, Michael Zech(Helmholtz Zentrum München)
Cited by 5
Related Papers
GJB2 Mutations and Degree of Hearing Loss: A Multicenter Study
|The American Journal of Human Genetics|2005|562
Monogenic variants in dystonia: an exome-wide sequencing study
|The Lancet Neurology|2020|218
Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial
|The Lancet Neurology|2015|213
Efficacy and safety of abobotulinumtoxinA in spastic lower limb
|Neurology|2017|96
Paroxysmal exercise‐induced dystonia within the phenotypic spectrum of <i>ECHS1</i> deficiency
|Movement Disorders|2016|78